Cord blood transplant for severe aplastic anemia
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests a new type of transplant using donated cord blood for adults with aplastic anemia that has not improved with standard treatments. It aims to see if the transplant is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 49 years old.
- You have aplastic anemia that did not get better with standard treatments like ATG and cyclosporine, or it came back after treatment.
- You do not have a matched brother, sister, or unrelated donor available.
- You are generally healthy enough for a transplant (Karnofsky score 60 or higher).
- You have not had a stem cell transplant before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
This trial tests a new way of using a mix of donor stem cells (from a half-matched family member and a cord blood unit) to treat aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if this transplant approach is safe and helps rebuild healthy blood cells.
This trial tests a special type of cord blood transplant using lab-grown stem cells to help the new blood-forming cells “take” sooner. It’s for people with severe aplastic anemia or certain MDS cases who have not responded well to standard immune-suppressing treatments.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This trial tests two different sources of donor cells for a transplant in patients with severe aplastic anemia (a condition where the bone marrow stops making enough blood cells). The study compares using cells from blood alone versus cells from both bone marrow and blood, to see which approach works better.
Hear when a new Aplastic Anemia Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.